Evidence map›Paper›PMID 20462863›Full record

ArticleNucleic acids research2010

Requirements for catalysis in the Cre recombinase active site.

Bryan Gibb, Kushol Gupta, Kaushik Ghosh, Robert Sharp, James Chen, Gregory D Van Duyne

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. mBio · 2025
    Article
  5. Review
  6. Article
  7. Dynamics in Cre-loxP site-specific recombination.Current opinion in structural biology · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  12. Chemically Acylated tRNAs are Functional in Zebrafish Embryos.Journal of the American Chemical Society · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Frontiers in cellular and infection microbiology · 2021
    Article
  19. Article
  20. DNA binding induces aProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Bryan GibbDepartment of Biochemistry and Biophysics and Howard Hughes Medical Institute, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Kushol Gupta
Kaushik Ghosh
Robert Sharp
James Chen
Gregory D Van Duyne
Howard Hughes Medical Institute · USUniversity of Pennsylvania · US

Funding

STRUCTURAL BIOLOGY TRAINING PROGRAMT32GM008275 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI WAND, A. JOSHUA · 1988 to 2018
$6.0M
STEREOCHEMISTRY OF SITE SPECIFIC RECOMBINATIONR01GM055041 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI VAN DUYNE, GREGORY D · 1998 to 2006
$1.4M
Howard Hughes Medical InstituteNIGMS NIH HHS GM55041NIGMS NIH HHS R01 GM055041NIGMS NIH HHS T32 GM008275NIGMS NIH HHS T32GM008275
6 · The paper itself

Abstract

Members of the tyrosine recombinase (YR) family of site-specific recombinases catalyze DNA rearrangements using phosphoryl transfer chemistry that is identical to that used by the type IB topoisomerases (TopIBs). To better understand the requirements for YR catalysis and the relationship between the YRs and the TopIBs, we have analyzed the in vivo and in vitro recombination activities of all substitutions of the seven active site residues in Cre recombinase. We have also determined the structure of a vanadate transition state mimic for the Cre-loxP reaction that facilitates interpretation of mutant activities and allows for a comparison with similar structures from the related topoisomerases. We find that active site residues shared by the TopIBs are most sensitive to substitution. Only two, the tyrosine nucleophile and a conserved lysine residue that activates the 5'-hydroxyl leaving group, are strictly required to achieve >5% of wild-type activity. The two conserved arginine residues each tolerate one substitution that results in modest recombination activity and the remaining three active site positions can be substituted with several alternative amino acids while retaining a significant amount of activity. The results are discussed in the context of YR and TopIB structural models and data from related YR systems.

Indexed as

Amino Acid SequenceAmino Acid SubstitutionArginineBiocatalysisCatalytic DomainGlutamic AcidHistidineIntegrasesLysineModels, MolecularMolecular Sequence DataRecombination, GeneticTryptophanTyrosineVanadatesArginineCre recombinaseGlutamic AcidHistidineIntegrasesLysineTryptophanTyrosineVanadates

Identifiers

PMID20462863
PMCPMC2943603
OpenAlexW1999140385

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.